This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an expansion of Glenmark’s injectable portfolio.

1 Glenmark's Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the ...

On March 3, 2025, Glenmark Pharmaceuticals announced that it has acquired Acetylcysteine Injection for sale in the United States. As part of the expansion move into US injectable drug market ...

Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...

MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the Acquisition and launch 1 of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials.